Bristol-Myers Squibb Company (BMYB34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 19 Oct 2026
Key indicators
| Last close | BRL 296.57 |
|---|---|
| 52-week range | 223.03 – 349.41 |
| Return, 1 month / 3 months | −10.7% / −3.9% |
| Return, 1 year / 3 years | +26.5% / +10.3% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 31.1% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 0.02M BRL |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bristol-Myers Squibb is a pharmaceutical company based in the United States that discovers, develops and markets prescription medicines. Its products treat serious diseases including several forms of cancer, immune disorders, cardiovascular conditions and viral infections. The company serves patients and healthcare providers through hospitals, clinics and pharmacies, and it also produces biologics and other therapies for chronic and life-threatening illnesses. Its medicines reach markets around the world.
Bristol-Myers Squibb Company is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code BMYB34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bristol-Myers Squibb Company (BMYB34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 296.57 on 19 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 557 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.5% and over the last three months it fell 3.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.0% | ||
| From 52-week high | -15.1% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.9% | ||
| 6-month return | 2.0% | ||
| 12-month return, skipping the last month | 41.6% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M BRL | ||
| Zero-volume days | 65.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −10.6% |
|---|---|
| 1 month | −10.7% |
| 3 months | −3.9% |
| 6 months | +2.0% |
| 1 year | +26.5% |
| 3 years | +10.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 328.79 / 305.76 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jul 2026 | USD 2.1139 |
| 1 Apr 2026 | USD 2.0562 |
| 30 Dec 2025 | USD 2.2809 |
| 2 Oct 2025 | USD 2.1983 |
| 2 Jul 2025 | USD 2.2706 |
| 3 Apr 2025 | USD 2.3150 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.